Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 447546

Interleukin-17 in experimental Klebsiella sepsis


Vasiljev Marchesi, Vanja; Rukavina, Tomislav
Interleukin-17 in experimental Klebsiella sepsis // Periodicum biologorum, 113 (2011), 99-102 (međunarodna recenzija, kratko priopcenje, znanstveni)


CROSBI ID: 447546 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Interleukin-17 in experimental Klebsiella sepsis

Autori
Vasiljev Marchesi, Vanja ; Rukavina, Tomislav

Izvornik
Periodicum biologorum (0031-5362) 113 (2011); 99-102

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni

Ključne riječi
Interleukin-17; Klebsiella pneumoniae; sepsis

Sažetak
Background and pupose: Interleukin-17 (IL-17) is a cytokine that was described to be important in pathogenesis of several inflammatory conditions. Literature data suggest that modulation of IL-17 production or its biological effects may be beneficial in order to control the level of inflammation. However, data regarding its possible role in the pathogenesis of systemic infections are sparse. Materials and methods: Therefore, we decided to examine the kinetics of systemic IL- 17 production in our model of experimental murine Klebsiella sepsis. We also examined IL- 17 production in mice treated with anti- lipopolysaccharide (anti-LPS) antibody prior to infection in order to see whether this pre- treatment, that was previously shown to significantly enhance the survival, is associated with changes in IL-17 production pattern. Results: Our results show that experimental Klebsiella sepsis is associated with an increased systemic IL-17 production. The increase in production is much greater in saline pre-treated group compared with anti-LPS pre-treated animals. Conclusions: We concluded that high levels of IL-17 in the blood may contribute the mortality in mice with systemic Klebsiella infection. We also concluded that diminished IL-17 production in anti-LPS pre- treated animals is, at least partially, responsible for greater survival in this group.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
062-0621273-0951 - Imunološki aspekti teških Klebsiella infekcija (Rukavina, Tomislav, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Rijeka,
Nastavni zavod za javno zdravstvo "Dr. Andrija Štampar"

Profili:

Avatar Url Vanja Vasiljev (autor)

Avatar Url Tomislav Rukavina (autor)


Citiraj ovu publikaciju:

Vasiljev Marchesi, Vanja; Rukavina, Tomislav
Interleukin-17 in experimental Klebsiella sepsis // Periodicum biologorum, 113 (2011), 99-102 (međunarodna recenzija, kratko priopcenje, znanstveni)
Vasiljev Marchesi, V. & Rukavina, T. (2011) Interleukin-17 in experimental Klebsiella sepsis. Periodicum biologorum, 113, 99-102.
@article{article, author = {Vasiljev Marchesi, Vanja and Rukavina, Tomislav}, year = {2011}, pages = {99-102}, keywords = {Interleukin-17, Klebsiella pneumoniae, sepsis}, journal = {Periodicum biologorum}, volume = {113}, issn = {0031-5362}, title = {Interleukin-17 in experimental Klebsiella sepsis}, keyword = {Interleukin-17, Klebsiella pneumoniae, sepsis} }
@article{article, author = {Vasiljev Marchesi, Vanja and Rukavina, Tomislav}, year = {2011}, pages = {99-102}, keywords = {Interleukin-17, Klebsiella pneumoniae, sepsis}, journal = {Periodicum biologorum}, volume = {113}, issn = {0031-5362}, title = {Interleukin-17 in experimental Klebsiella sepsis}, keyword = {Interleukin-17, Klebsiella pneumoniae, sepsis} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus





Contrast
Increase Font
Decrease Font
Dyslexic Font